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Background:
Although being increasingly applied, blood collection for drug testing in sport presents some logistic issues that complicate full applicability on a large scale. The use of dried blood spots (DBS) could benefit compliant blood testing considerably owing to its simplicity, minimal invasiveness, analyte stability and reduced costs. The aim of this study was to evaluate the applicability of DBS to the methodology approved by the World Anti-Doping Agency (WADA) for detection of doping by recombinant human growth hormone (rhGH) in serum.
Methods:
A protocol for a single DBS analysis using the hGH isoforms differential immunoassays (Kit 1 and Kit 2) was developed and validated. A clinical study with healthy volunteers injected for three consecutive days with a low subcutaneous dose (1) . The use of its recombinant analogue is believed to be 3 widespread in sports as a performance-enhancing substance and therefore the 4 recombinant compound has been included in the WADA Prohibited List (2). The 5 direct method to detect recombinant hGH (rhGH) abuse in sport is based on the 6 quantification of hGH variants in serum using monoclonal antibodies (mAb) (3;4). 7 Endogenous hGH is present in several isoforms with different structures (22-kDa, 8 20-kDa, acidic GH, and others) and different aggregation status (monomers, dimers, 9 oligomers) (1;5). The rhGH, commercially produced for therapeutic use, corresponds 10 to the 22-kDa isoform and after administration it becomes predominant in the body 11 (1;3). The doping strategy takes advantage of this fact and the hGH isoforms test 12 has been developed based on two separate immunoassays applied to blood serum 13 (3;6) . The first assay (named "rec") contains a capture antibody that preferentially 14 recognizes the 22-kDa isoform whereas the second assay (named "pit") has a 15 capture antibody that binds to a broader number of pituitary isoforms present in the 16 body (1;4). The detection antibody, common to both assays, recognizes the 22-kDa 17 isoform bound by the capture antibody (4) . Administration of rhGH, by increasing the 18 22-kDa isoform and producing some suppression of the endogenous hGH forms, 19 increases the relative ratio between the "rec GH" and "pit GH", thereby providing 20 evidence of administration of the prohibited form (1;4). Specifically, WADA guidelines 21 demand the application of two different tests (kit 1 and kit 2; both involving "rec" and 22 "pit" assays, with different capture antibodies) to the sample to validate and confirm 23 positivity (6) . The corresponding Decision Limit (DL) for males, established in WADA 24 technical documents, is recGH/pitGH ratio 1.84 for kit 1 and 1.91 for kit 2 (6;7). Dried 25 blood spots (DBS) analysis has been used for newborn screening to detect 26 biomarkers of certain diseases for more than 50 years (8) . In recent times, this type 27 of analysis has gained interest in areas such as drug development, toxicology and 28 clinical diagnosis (9) (10) (11) . DBS involve the deposition onto a specific filter paper of 29 drops of blood collected via finger or heel prick (11;12) . Compared to traditional 30 sampling collection, DBS offer benefits including minimal invasiveness, easier 31 storage and transport, and longer stability, thereby constituting a promising matrix for 32 anti-doping purposes (9;11;12) . Current protocols for venous blood collection of anti-33 doping samples require a licensed phlebotomist under the supervision of a doping 34 control officer and the need to dispatch samples as soon as possible after collection, 35 ideally arriving at the anti-doping accredited laboratory on the same collection day, 36 and preferably within 36 h of collection (13) . The conditions required by these hormones, indicating the growing interest in the field (14) (15) (16) (17) (18) (19) . In these cases, 44 protocols have relied on mass spectrometry technologies to quantify banned drugs, 45 but the appropriateness of DBS use for detection of doping substances using 46 immunoassays included in WADA guidelines has received very little attention. 47 Nevertheless, many published papers support the reliability of dried blood measures 48 for a growing list of proteins by using antibody binding based techniques (20) (21) (22) 
Results

131
Method validation
132
The performance of hGH isoforms test using a single DBS was studied (see Table   133 1). As the real amount of serum analyzed by each single spot was lower than the Fig. 1C and 1D ) was marginally higher for DBS (r=0.97) than for serum (r=0.94) and the correlation between DBS and serum indicated linearity for kit 1 (r=0.93) and 173 kit 2 (r=0.93) (Fig. 1E and 1F) . 174 
Clinical trial with eight treated individuals
175
Following the results of the pilot study, the eight individuals included in the clinical 176 trial were submitted to the same protocol as those in the pilot study, namely, a dose 177 of rhGH once daily for three days. Biological samples (DBS and serum) for half of 178 them were analyzed with kit 1 and the other half with kit 2 (Fig. 2) . The analysis of (Fig. 3) 
Discussion
218
The aim of this study was to explore the application possibilities of DBS matrix for 219 blood anti-doping sampling purposes using the current analytical method to detect 220 rhGH abuse approved by the World Anti-Doping Agency. In fact, the suggestion of 221 alternative matrices for rhGH analysis is not new, as urine also has been proposed 222 recently (23) . We have tested a DBS-based methodology that can be successfully 223 applied to the current protocols to detect rhGH misuse with a window of detection up 224 to 8-12 h analyzing a single blood spot as DBS.
225
Classic workflow for DBS analysis involves the partial punching of a 3-6 mm 226 diameter disc followed by extraction protocol and posterior analysis (24) . This 227 approach raises DBS critical issues like hematocrit effect and heterogeneous 228 distribution of blood on the card. In the present study, these problems have been 229 avoided by extracting the whole spot as has been previously proposed (24) . In 230 addition, the measurement of the isoforms ratio has eliminated another concern, the 231 influence of spotted blood volume, because isoform proportions are expected to be 232 maintained independently of the volume deposited in the spot. 233 The validation of a method for the use of one single DBS has been developed. 234 Owing to a reduced sample volume of sample, functional sensitivity values of DBS 235 were found to be lower (higher concentrations) than those determined in serum 236 samples by the standard method. Nevertheless, intraday precision and interday 237 precision CV<20% indicate suitability of the method for bioanalytical purposes. 238 Furthermore, linearity appeared adequate for the purposes of anti-doping controls. 
Limit of detection (LOD, analytical sensitivity)
LOD was evaluated as described (2) . Briefly, 10 separated single DBSs with the zero standard calibrator (modeled blood) were analyzed with kit 1 and kit 2 and the limit was established as the mean plus 2SD.
Lower limit of quantification (LLOQ, functional sensitivity)
LLOQ was determined from serial dilutions of a clinical trial serum sample (pitGH 8.52 µg/L by kit 2) modeled as blood sample down to obtain a CV not to exceed 20% when analyzed as a single DBS.
Intra-assay and inter-assay precision
Intra-assay precision was determined by measurement of six DBS prepared as modeled blood with three different serum samples from the clinical study with three levels of hGH (pitGH range 0.04 -4.43 µg/L by kit 2). Inter-assay precision was calculated using the six replicates at each concentration level over three days and the ranges of precision were obtained from the 18 samples. The summary of the impact on recovery due to different variables (volume, filter card paper, type of sample and GH source) is presented in Table S1 .
Anatomical blood origin effect
DBS prepared from finger prick and from whole blood (25 µL 
Stability
A set of sixteen duplicated DBS samples collected from eight subjects submitted to the clinical trial and maintained for 26 days either at room temperature or under cold conditions were studied. Additional purpose was also the simulation of prospective situations for actual doping control including transport of specimens at room temperature. Therefore, samples that were maintained at room temperature, included a round intercontinental air flight (7 hours each arm). For stability of rhGH in cards stored either under refrigeration or at room temperature (including a transcontinental return flight simulating actual potential transport of DBS samples), the analysis of recGH, pitGH and the ratio recGH/pit/GH showed similar results in either condition tested and all values were under a ±15% of variation, as presented in Figure S1 . 
